|
US20040157280A1
(en)
*
|
2001-09-17 |
2004-08-12 |
Paul Wentworth |
Antibody mediated ozone generation
|
|
US20050129680A1
(en)
*
|
2001-09-17 |
2005-06-16 |
Paul Wentworth |
Antimicrobial activity of antibodies
|
|
US20040116350A1
(en)
*
|
2001-09-17 |
2004-06-17 |
Paul Wentworth Jr |
Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
|
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
EP1563299A2
(en)
*
|
2002-11-14 |
2005-08-17 |
Novartis AG |
Antibody- or neutrophil-mediated ozone generation
|
|
GB0313916D0
(en)
*
|
2003-06-16 |
2003-07-23 |
Glaxosmithkline Biolog Sa |
Vaccine composition
|
|
JP4860109B2
(ja)
*
|
2003-12-26 |
2012-01-25 |
バイオリーダース・コーポレイション |
ポリガンマグルタミン酸を含む免疫増強用組成物
|
|
DE102006047617B4
(de)
*
|
2006-10-09 |
2008-11-27 |
Clariant International Limited |
Verfahren zur Herstellung basischer (Meth)acrylamide
|
|
US20090017064A1
(en)
*
|
2007-07-10 |
2009-01-15 |
Wyeth |
Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
|
|
FR2922767B1
(fr)
|
2007-10-24 |
2009-12-18 |
Seppic Sa |
Procede de preparation d'une composition vaccinale comprenant au moins un antigene et au moins un adjuvant.
|
|
BRPI0820341B1
(pt)
|
2007-11-06 |
2021-11-09 |
Zoetis Services Llc |
Composição imunogênica para uso na proteção de um animal contra uma doença associada a uma cepa virulenta de mycoplasma hyopneumoniae
|
|
EP2062594A1
(en)
*
|
2007-11-21 |
2009-05-27 |
Wyeth Farma, S.A. |
Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same
|
|
DE102008017216B4
(de)
*
|
2008-04-04 |
2013-08-14 |
Clariant International Ltd. |
Kontinuierliches Verfahren zur Herstellung von Fettsäureamiden
|
|
TW201010719A
(en)
*
|
2008-08-19 |
2010-03-16 |
Wyeth Corp |
Immunological composition
|
|
GB0907989D0
(en)
|
2009-05-08 |
2009-06-24 |
Hybrid Systems Ltd |
Multivalent adjuvant display
|
|
TWI505834B
(zh)
|
2009-06-22 |
2015-11-01 |
Wyeth Llc |
組合物及製備金黃色葡萄球菌血清型５及８莢膜多醣結合物之免疫原性組合物之方法
|
|
BRPI1015567A2
(pt)
|
2009-06-22 |
2021-08-31 |
Wyeth Llc |
Composições imunogênicas de antígenos de staphylococcus aureus
|
|
DE102009031059A1
(de)
|
2009-06-30 |
2011-01-05 |
Clariant International Ltd. |
Vorrichtung zur kontinuierlichen Durchführung chemischer Reaktionen bei hohen Temperaturen
|
|
US20110110980A1
(en)
|
2009-09-02 |
2011-05-12 |
Wyeth Llc |
Heterlogous prime-boost immunization regimen
|
|
DE102009042522A1
(de)
|
2009-09-22 |
2011-04-07 |
Clariant International Ltd. |
Kontinuierliches Umesterungsverfahren
|
|
DE102009042523B4
(de)
|
2009-09-22 |
2012-02-16 |
Clariant International Ltd. |
Vorrichtung und Verfahren zur kontinuierlichen Durchführung heterogen katalysierter chemischer Reaktionen bei hohen Temperaturen
|
|
CA2807266C
(en)
|
2010-08-04 |
2020-03-24 |
Pierrel Pharma S.R.L. |
Supramolecular complexes of polyanionic polymers and spermidine in tissue maintenance and repair
|
|
PL3831406T3
(pl)
|
2010-08-23 |
2024-09-09 |
Wyeth Llc |
Stabilne preparaty antygenów rLP2086 Neisseria meningitidis
|
|
RU2546873C2
(ru)
|
2010-09-10 |
2015-04-10 |
УАЙТ ЭлЭлСи |
Нелипидизированные варианты антигенов neisseria meningitidis orf2086
|
|
RU2570730C2
(ru)
|
2010-12-22 |
2015-12-10 |
УАЙТ ЭлЭлСи |
Стабильные иммуногенные композиции антигенов staphylococcus aureus
|
|
DE102010056565A1
(de)
|
2010-12-30 |
2012-07-05 |
Clariant International Ltd. |
Verfahren zur Modifizierung Hydroxylgruppen tragender Polymere
|
|
DE102010056564A1
(de)
|
2010-12-30 |
2012-07-05 |
Clariant International Limited |
Hydroxylgruppen und Estergruppen tragende Polymere und Verfahren zu ihrer Herstellung
|
|
DE102010056566A1
(de)
*
|
2010-12-30 |
2012-07-05 |
Clariant International Ltd. |
Kontinuierliches Verfahren zur Veresterung Säuregruppen tragender Polymere
|
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
|
MY167723A
(en)
|
2012-03-09 |
2018-09-21 |
Pfizer |
Neisseria meningitidis compositions and methods thereof
|
|
UA114504C2
(uk)
|
2012-04-04 |
2017-06-26 |
Зоетіс Сервісіз Ллс |
Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
|
|
US9120859B2
(en)
|
2012-04-04 |
2015-09-01 |
Zoetis Services Llc |
Mycoplasma hyopneumoniae vaccine
|
|
UA114503C2
(uk)
|
2012-04-04 |
2017-06-26 |
Зоетіс Сервісіз Ллс |
Комбінована вакцина pcv та mycoplasma hyopneumoniae
|
|
KR101980989B1
(ko)
|
2012-12-20 |
2019-05-21 |
화이자 인코포레이티드 |
당접합 방법
|
|
US9802987B2
(en)
|
2013-03-08 |
2017-10-31 |
Pfizer Inc. |
Immunogenic fusion polypeptides
|
|
EP4098276A1
(en)
|
2013-09-08 |
2022-12-07 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
EP3049106A1
(en)
|
2013-09-25 |
2016-08-03 |
Zoetis Services LLC |
Pcv2b divergent vaccine composition and methods of use
|
|
US10888611B2
(en)
|
2015-02-19 |
2021-01-12 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
IL255106B2
(en)
|
2015-05-04 |
2023-04-01 |
Pfizer |
Protein-polysaccharide conjugates of group b streptococcus, methods for preparing conjugates, immunogenic preparations containing conjugates and their uses
|
|
DK3471760T3
(da)
*
|
2016-06-17 |
2025-01-27 |
Boehringer Ingelheim Vetmedica Gmbh |
Hidtil ukendte immunogene formuleringer, der omfatter lineære eller forgrenede polyacrylsyrepolymeradjuvanser
|
|
US10751402B2
(en)
|
2016-11-09 |
2020-08-25 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
|
PE20191107A1
(es)
|
2017-01-31 |
2019-08-26 |
Pfizer |
Composiciones de neisseria meningitidis y metodos respectivos
|
|
CA3093709C
(en)
|
2018-03-16 |
2024-03-26 |
Zoetis Services Llc |
Peptide vaccines against interleukin-31
|
|
CN109134724A
(zh)
*
|
2018-07-24 |
2019-01-04 |
石家庄哈顿生物技术有限公司 |
一种动物疫苗用聚丙烯酸类聚合物佐剂的研制方法
|
|
WO2021059181A1
(en)
|
2019-09-27 |
2021-04-01 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
EP4203995A1
(en)
|
2020-08-26 |
2023-07-05 |
Pfizer Inc. |
Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
|
|
WO2026038177A1
(en)
|
2024-08-16 |
2026-02-19 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|